These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21480382)

  • 21. Varenicline: the French experience after 6 months.
    Prescrire Int; 2009 Feb; 18(99):25. PubMed ID: 19396936
    [No Abstract]   [Full Text] [Related]  

  • 22. Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.
    Ismail Z; Syms J; Blumberger D; George TP
    Schizophr Res; 2010 Jun; 119(1-3):268. PubMed ID: 20178890
    [No Abstract]   [Full Text] [Related]  

  • 23. Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders.
    Castle D; Baker AL; Richmond R; Filia SL; Harris D; Pirola-Merlo AJ
    Ann Clin Psychiatry; 2012 Nov; 24(4):285-91. PubMed ID: 23145385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varenicline for smoking cessation.
    Harrison-Woolrych M
    BMJ; 2012 Nov; 345():e7547. PubMed ID: 23138037
    [No Abstract]   [Full Text] [Related]  

  • 25. Varenicline and pheochromocytoma.
    Hukkanen J; Ukkola O; Benowitz NL
    Ann Intern Med; 2010 Mar; 152(5):335-6. PubMed ID: 20194248
    [No Abstract]   [Full Text] [Related]  

  • 26. Summaries for patients. Does varenicline help people with depression quit smoking?
    Ann Intern Med; 2013 Sep; 159(6):I-36. PubMed ID: 24042380
    [No Abstract]   [Full Text] [Related]  

  • 27. Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder.
    Forcen FE; Martinez FL; Moya AM
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):221-3. PubMed ID: 22182460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Australia's experience with varenicline: usage, costs and adverse reactions.
    Walsh RA
    Addiction; 2011 Feb; 106(2):451-2. PubMed ID: 21208325
    [No Abstract]   [Full Text] [Related]  

  • 29. Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
    Lyon GJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):720-1. PubMed ID: 19011454
    [No Abstract]   [Full Text] [Related]  

  • 30. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empowering dental hygienists: tobacco cessation resources.
    Perno Goldie M
    Int J Dent Hyg; 2008 May; 6(2):148-9. PubMed ID: 18412729
    [No Abstract]   [Full Text] [Related]  

  • 32. Varenicline: aggression and homicidal ideation.
    Prescrire Int; 2012 Feb; 21(124):42-3. PubMed ID: 22413719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!
    Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119
    [No Abstract]   [Full Text] [Related]  

  • 34. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New reports examine psychiatric risks of varenicline for smoking cessation.
    Kuehn BM
    JAMA; 2012 Jan; 307(2):129-30. PubMed ID: 22235073
    [No Abstract]   [Full Text] [Related]  

  • 36. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
    DiPaula BA; Thomas MD
    Pharmacotherapy; 2009 Jul; 29(7):852-7. PubMed ID: 19558259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
    Harrison-Woolrych M; Ashton J
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
    McColl SL; Burstein AH; Reeves KR; Billing CB; Stolar M; Sellers EM
    Clin Pharmacol Ther; 2008 Apr; 83(4):607-14. PubMed ID: 18288085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thoughts and acts of aggression/violence toward others reported in association with varenicline.
    Moore TJ; Glenmullen J; Furberg CD
    Ann Pharmacother; 2010 Sep; 44(9):1389-94. PubMed ID: 20647416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.